The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Sandoz
Stock and Other Ownership Interests - Sandoz
Travel, Accommodations, Expenses - Sandoz
Cost savings of conversion from filgrastim or pegfilgrastim to biosimilar filgrastim-sndz for chemotherapy-induced (febrile) neutropenia (CIN/FN) prophylaxis and expanded access to biosimilar GCSF on a budget neutral basis.
 
Ali McBride
Consulting or Advisory Role - Lilly; Pfizer
Speakers' Bureau - Sandoz
Research Funding - Sanofi
 
Ivo Abraham
Consulting or Advisory Role - Alcon; Evofem; Novartis; Sandoz
 
Karen MacDonald
Consulting or Advisory Role - Alcon; Evofem; Novartis; Sandoz
 
Kim Campbell
No Relationships to Disclose
 
Mohan Bikkina
Employment - Sandoz
Stock and Other Ownership Interests - Novartis; Pfizer
 
Sanjeev Balu
Employment - Sandoz
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis; Sandoz